Save on prescription drugs with this exclusive offer!

Find the Best Medicare Advantage Plans for Seniors

Men Who Delay Radical Treatment of Prostate Cancer Don’t Seem to Worry About It

Men with neurotic personalities and those in poor physical health exhibited more anxiety and distress than others

July 27, 2009 - Living with untreated cancer is not upsetting for many patients with early prostate cancer, according to a new study in Cancer, a journal of the American Cancer Society. Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress, the study found.

	Related Stories
	Heavy Alcohol Drinking Spurs High-Grade Prostate Cancer, Stops Prevention by Finasteride Four or more drinks on 5 or more days per week doubles risk of high-grade prostate cancer July 13, 2009 Predicting the Return of Prostate Cancer Improved by Results from John Hopkins Study May also help resolve the debate on when, and in what form, secondary treatments should occur July 2, 2009 PARP Drugs May Be Miracle Cure for Cancer Suggests Success with Breast, Ovarian, Prostate Cancer NEJM editorial says PARP inhibitors may point to a new direction for anticancer drugs - watch video June 25, 2009 Veterans Badly Mistreated for Prostate Cancer at VA Hospital, Reports NY Times 92 of 116 cancer treatments were botched during a six year period at Philadelphia unit June 22, 2009 Prostate Cancer Test Proven to Offer Early Prediction of Bone Metastasis, Mortality UCSF Cancer of the Prostate Risk Assessment gives patients and doctors a better way of gauging long-term risks and pinpointing high risk cases. June 15, 2009 New Blood Test Significantly Increases Accuracy of PSA Screening for Prostate Cancer Greatly reduces false-positives in prostate cancer screening that often require a biopsy of the gland to check for tumors May 28, 2009 Men Should Not Give Up on PSA Prostate Cancer Screening, Just Yet Urologists argue that men should not be swayed from getting the test - it still saves lives May 13, 2009 Read the latest news on Senior Health & Medicine

The rapid increase in the use of screening using prostate specific antigen (PSA) testing has led to a large number of men diagnosed with prostate cancer, many of who do not require treatment.

In these cases, close clinical monitoring—or active surveillance—is often recommended. If progression of the cancer occurs during active surveillance, patients may undergo radical therapy. While active surveillance may delay or even avoid the possible adverse side effects of radical treatment, it could also cause psychological harm in patients because they must live with untreated cancer. Data on the levels of such potentially negative emotions among men on active surveillance are lacking, however.

Roderick van den Bergh, (MD), of the Erasmus Medical Center, in Rotterdam, the Netherlands, and colleagues assessed levels of anxiety and distress in a group of recently diagnosed prostate cancer patients on active surveillance.

They sent 150 men questionnaires to gauge uncertainty about their treatment decision, as well as levels of depression and anxiety among these men. A total of 129 questionnaires were completed and returned an average of 2.7 months after diagnosis. More than 80 percent of the 129 respondents scored favorably low on the parameters measured. Patients' scores were comparable or favorable to scores of men (reported in other studies) who underwent treatment for early prostate cancer.

Certain men in the study - such as men with neurotic personalities and those who were in poor physical health - exhibited more anxiety and distress than others. These findings indicate that besides cancer-specific factors, mental and physical patient-specific factors are important aspects to take into account when selecting men for active surveillance.

The results also suggest that psychological support may be indicated in certain patients undergoing active surveillance.

While this study's findings are useful, Dr. van den Bergh noted that longer-term analyses are needed on the psychological effects of active surveillance in men with early prostate cancer. His research team is currently conducting such a study.

The study is published in the September 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. See reference below.

Article: "Anxiety and distress during active surveillance for early prostate cancer." Roderick C.N. van den Bergh, Marie-Louise Essink-Bot, Monique J. Roobol, Tineke Wolters, Fritz H. Schrφder, Chris H. Bangma, and Ewout W. Steyerberg. Cancer; Published Online: July 27, 2009 (DOI: 10.1002/cncr.24446); Print Issue Date: September 1, 2009.

Keep up with the latest news for senior citizens, baby boomers